Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
74.56
-2.35 (-3.06%)
At close: May 11, 2026, 4:00 PM EDT
74.57
+0.01 (0.01%)
After-hours: May 11, 2026, 5:13 PM EDT
Cytokinetics Analyst Ratings
Total Analysts
19
Consensus Rating
Strong Buy
Price Target
$94.16
Upside
+26.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $136 → $140 | Strong Buy | Maintains | $136 → $140 | +87.77% | May 11, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $95 → $105 | Buy | Maintains | $95 → $105 | +40.83% | May 7, 2026 |
| Stifel | Stifel | Strong Buy Maintains $98 → $108 | Strong Buy | Maintains | $98 → $108 | +44.85% | May 6, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $90 → $103 | Buy | Maintains | $90 → $103 | +38.14% | May 6, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $101 → $119 | Buy | Maintains | $101 → $119 | +59.60% | May 6, 2026 |
| Needham | Needham | Strong Buy Maintains $85 → $102 | Strong Buy | Maintains | $85 → $102 | +36.80% | May 5, 2026 |
| Wells Fargo | Wells Fargo | Buy Initiates $95 | Buy | Initiates | $95 | +27.41% | Apr 10, 2026 |
| Barclays | Barclays | Buy Maintains $87 → $95 | Buy | Maintains | $87 → $95 | +27.41% | Apr 6, 2026 |
| Mizuho | Mizuho | Buy Maintains $84 → $100 | Buy | Maintains | $84 → $100 | +34.12% | Mar 18, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $74 → $75 | Buy | Maintains | $74 → $75 | +0.59% | Mar 17, 2026 |
| UBS | UBS | Hold Maintains $61 → $69 | Hold | Maintains | $61 → $69 | -7.46% | Mar 6, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $83 → $84 | Buy | Maintains | $83 → $84 | +12.66% | Feb 26, 2026 |
| Citizens | Citizens | Buy Maintains $88 → $96 | Buy | Maintains | $88 → $96 | +28.76% | Feb 25, 2026 |
| Needham | Needham | Strong Buy Maintains $84 → $85 | Strong Buy | Maintains | $84 → $85 | +14.00% | Feb 25, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $95 → $101 | Buy | Maintains | $95 → $101 | +35.46% | Feb 20, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $84 → $92 | Strong Buy | Maintains | $84 → $92 | +23.39% | Feb 3, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.